This alternating strategy gives you the absorption benefits of abdominal injection most of the time while protecting against excessive side effects during transitions
We see this in regards to reducing the pleasure-seeking around alcohol, nicotine, and potentially sex drives. The evidence surrounding changed sexual function is limited, and mixed
Recent Findings Retatrutide is the first triple agonist (acting on GLP-1/GIP/glucagon receptors) with published phase 2 data in people with obesity as well as in people with T2D
The integration of GLP-1 receptor agonists, such as semaglutide and liraglutide, into our practice aligns with our mission to provide effective, medically supervised weight loss options that complement our surgical and non-surgical aesthetic offerings
You will need to show up for clinic visits regularly, sometimes for over a year
Most patients find their ideal window within the first month and rarely need to change it again